• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Understanding Autoantibody Screening Tests: Methods, Interpretation, and Analysis Practicalities

Opinion
Video

Schafer Boeder, MD and Andrea Stallings, PA delve into the intricacies of autoantibody screening tests for T1D with detailed insights on their methodologies, interpretation nuances, and practical analysis considerations.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
      Impact of Social Determinants of Health on Key Cardiometabolic Measures Amplified by New Research
      Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
      Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
      US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
      US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
      Beyond HbA1c: Take a Global Approach to Type 2 Diabetes Management, Use all the Tools
      Beyond HbA1c: Take a Global Approach to Type 2 Diabetes Management, Use all the Tools
      Lessons Learned from the VA on Delay in Second-line Treatment for Type 2 Diabetes
      Lessons Learned from the VA on Delay in Second-line Treatment for Type 2 Diabetes
      VA Clinical Investigator Discusses HbA1c, Comorbidities as Markers for T2D Treatment Intensification
      VA Clinical Investigator Discusses HbA1c, Comorbidities as Markers for T2D Treatment Intensification
      DiabetesWise Pro: Side-by-side, Feature-by-feature CGM Comparison, Plus More
      DiabetesWise Pro: Side-by-side, Feature-by-feature CGM Comparison, Plus More
      A Guide to Prescribing the Right Diabetes Device for your Patients, with DiabetesWise Pro Developer Korey Hood, PhD
      A Guide to Prescribing the Right Diabetes Device for your Patients, with DiabetesWise Pro Developer Korey Hood, PhD
      Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
      Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
      Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
      Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
      Related Content
      GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes / image credit ©Visualmind/stock.adobe.com

      GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes

      Grace Halsey
      July 24th 2025
      Article

      Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.

      Obesity & Type 2 Diabetes: An Expert Discussion

      Obesity & Type 2 Diabetes: An Expert Discussion

      Sydney Jennings
      June 30th 2023
      Podcast

      In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

      t New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

      New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

      Grace Halsey
      July 16th 2025
      Article

      ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.

      Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

      Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

      Sydney Jennings
      July 22nd 2022
      Podcast

      "Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

      Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial

      Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial

      Sydney Jennings
      July 7th 2025
      Article

      ADA 2025: Dapiglutide showed promising safety and weight loss results in a phase 1b trial, targeting obesity and inflammation with once-weekly dosing.

      Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

      Once-Monthly Maridebart Cafraglutide Produces Up to 20% Weight Loss in Phase 2 Trial

      Sydney Jennings
      June 26th 2025
      Article

      ADA 2025: Once-monthly dosing led to significant weight loss in adults with obesity, with or without type 2 diabetes, reported researchers.

      © 2025 MJH Life Sciences

      All rights reserved.